Skip to content
★ Sign in to follow
MR

Margo R. Roberts

Executive
Kite Pharma, Inc.
Total declarations
63
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (40 ops.)
€6.2M

Latest filing published 17 Mar 2016 for Kite Pharma, Inc., €4,729.

Insider track record

Disclosed buys
0
Disclosed sells
40
Signal history

Margo R. Roberts: trading record in brief

Margo R. Roberts appears in our data through filings on Kite Pharma, Inc. shares, published by SEC (Form 4). In total, 63 filings cover trades dated from 15 May 2015 to 15 March 2016.

The open-market record consists of 40 sales worth €6.2M, with no purchase. The rest of the record consists of 1 share grant and 22 option exercises. 2016 to date brings no purchases and 12 sales.

The record was last updated on 17 March 2016 with an option exercise (€4,729) in Kite Pharma, Inc. Typically, a trade is published a median of 2 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Margo R. Roberts

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations63 total
  • ◇
    Chief Scientific OfficerExecutivesKite Pharma, Inc.
    5,250 USD11SEC
    7,500 shares@ US$0.700.2% of flowCommon StockSEC:0001209191-16-109313:0
  • ◇
    Chief Scientific OfficerExecutivesKite Pharma, Inc.
    17,102 USD11SEC
    1,006 shares@ US$17.000.7% of flowCommon StockSEC:0001209191-16-109313:1
  • ▼
    Chief Scientific OfficerExecutivesKite Pharma, Inc.
    352,378 USD30SEC
    7,815 shares@ US$45.0914.7% of flowCommon StockSEC:0001209191-16-109313:2
  • ▼
    Chief Scientific OfficerExecutivesKite Pharma, Inc.
    20,204 USD29SEC
    436 shares@ US$46.340.8% of flowCommon StockSEC:0001209191-16-109313:3
  • ▼
    Chief Scientific OfficerExecutivesKite Pharma, Inc.
    12,184 USD29SEC
    255 shares@ US$47.780.5% of flowCommon StockSEC:0001209191-16-109313:4
  • ◇
    Chief Scientific OfficerExecutivesKite Pharma, Inc.
    6,038 USD11SEC
    8,625 shares@ US$0.700.3% of flowCommon StockSEC:0001209191-16-109312:0
  • ◇
    Chief Scientific OfficerExecutivesKite Pharma, Inc.
    17,119 USD11SEC
    1,007 shares@ US$17.000.7% of flowCommon StockSEC:0001209191-16-109312:1
  • ◇
    Chief Scientific OfficerExecutivesKite Pharma, Inc.
    6,742 USD11SEC
    9,632 shares@ US$0.700.3% of flowCommon StockSEC:0001209191-16-100472:0
  • ▼
    Chief Scientific OfficerExecutivesKite Pharma, Inc.
    429,417 USD31SEC
    9,532 shares@ US$45.0517.8% of flowCommon StockSEC:0001209191-16-100472:1
  • ▼
    Chief Scientific OfficerExecutivesKite Pharma, Inc.
    4,601 USD29SEC
    100 shares@ US$46.010.2% of flowCommon StockSEC:0001209191-16-100472:2
  • ▼
    Chief Scientific OfficerExecutivesKite Pharma, Inc.
    1M USD37SEC
    18,750 shares@ US$64.158177.3% of flowCommon StockSEC:0001209191-16-098979:1
  • ◇
    Chief Scientific OfficerExecutivesKite Pharma, Inc.
    0SEC
    18,750 sharesCommon StockSEC:0001209191-16-098979:0
  • ◇
    Chief Scientific OfficerExecutivesKite Pharma, Inc.
    0SEC
    5,500 sharesCommon StockSEC:0001209191-16-092245:0
  • ◇
    Chief Scientific OfficerExecutivesKite Pharma, Inc.
    0SEC
    645 sharesCommon StockSEC:0001209191-16-092245:1
  • ▼
    Chief Scientific OfficerExecutivesKite Pharma, Inc.
    11,546 USD29SEC
    200 shares@ US$57.730.8% of flowCommon StockSEC:0001209191-16-092245:7
  • ▼
    Chief Scientific OfficerExecutivesKite Pharma, Inc.
    58,845 USD29SEC
    1,054 shares@ US$55.833.9% of flowCommon StockSEC:0001209191-16-092245:5
  • ▼
    Chief Scientific OfficerExecutivesKite Pharma, Inc.
    22,760 USD29SEC
    400 shares@ US$56.901.5% of flowCommon StockSEC:0001209191-16-092245:6
  • ▼
    Chief Scientific OfficerExecutivesKite Pharma, Inc.
    13,857 USD29SEC
    264 shares@ US$52.490.9% of flowCommon StockSEC:0001209191-16-092245:2
  • ▼
    Chief Scientific OfficerExecutivesKite Pharma, Inc.
    194,549 USD30SEC
    3,527 shares@ US$55.1613.0% of flowCommon StockSEC:0001209191-16-092245:4
  • ▼
    Chief Scientific OfficerExecutivesKite Pharma, Inc.
    37,765 USD29SEC
    700 shares@ US$53.952.5% of flowCommon StockSEC:0001209191-16-092245:3
  • ◆
    Chief Scientific OfficerExecutivesKite Pharma, Inc.
    0SEC
    6,900 shares0Common StockSEC:0001209191-15-086485:0
  • ◇
    Chief Scientific OfficerExecutivesKite Pharma, Inc.
    3,850 USD0SEC
    5,500 shares@ US$0.70Common StockSEC:0001209191-15-085941:0
  • ◇
    Chief Scientific OfficerExecutivesKite Pharma, Inc.
    10,965 USD0SEC
    645 shares@ US$17.00Common StockSEC:0001209191-15-085941:1
  • ▼
    Chief Scientific OfficerExecutivesKite Pharma, Inc.
    163,176 USD0SEC
    2,600 shares@ US$62.76Common StockSEC:0001209191-15-085941:2
  • ▼
    Chief Scientific OfficerExecutivesKite Pharma, Inc.
    154,248 USD0SEC
    2,400 shares@ US$64.27Common StockSEC:0001209191-15-085941:3

25 of 63 declarations